About neuronetics inc - STIM
Neuronetics, Inc. is a commercial stage medical technology company, which focuses on designing, developing and marketing products that improve the quality of life for patients who suffer from neurohealth disorders. It operates through United States and International geographical segments. The company was founded by Steven B. Waite, Bruce J. Shook, Norman R. Weldon, and Thomas D. Weldon in 2003 and is headquartered in Malvern, PA.
STIM At a Glance
Neuronetics, Inc.
3222 Phoenixville Pike
Malvern, Pennsylvania 19355
| Phone | 1-610-640-4202 | Revenue | 149.16M | |
| Industry | Medical Specialties | Net Income | -38,998,000.00 | |
| Sector | Health Technology | 2025 Sales Growth | 99.168% | |
| Fiscal Year-end | 12 / 2026 | Employees | 658 | |
| View SEC Filings |
STIM Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 0.61 |
| Price to Book Ratio | 4.255 |
| Price to Cash Flow Ratio | N/A |
| Enterprise Value to EBITDA | -5.40 |
| Enterprise Value to Sales | 1.013 |
| Total Debt to Enterprise Value | 0.598 |
STIM Efficiency
| Revenue/Employee | 226,682.371 |
| Income Per Employee | -59,267.477 |
| Receivables Turnover | 8.713 |
| Total Asset Turnover | 1.056 |
STIM Liquidity
| Current Ratio | 2.017 |
| Quick Ratio | 1.875 |
| Cash Ratio | 1.118 |
STIM Profitability
| Gross Margin | 47.472 |
| Operating Margin | -21.076 |
| Pretax Margin | -26.237 |
| Net Margin | -26.146 |
| Return on Assets | -27.614 |
| Return on Equity | -155.73 |
| Return on Total Capital | -34.609 |
| Return on Invested Capital | -36.676 |
STIM Capital Structure
| Total Debt to Total Equity | 403.535 |
| Total Debt to Total Capital | 80.14 |
| Total Debt to Total Assets | 63.795 |
| Long-Term Debt to Equity | 378.684 |
| Long-Term Debt to Total Capital | 75.205 |